Common genetic polymorphisms affect the human requirement for the nutrient choline - PubMed (original) (raw)
Comparative Study
Common genetic polymorphisms affect the human requirement for the nutrient choline
Kerry-Ann da Costa et al. FASEB J. 2006 Jul.
Abstract
Humans eating diets deficient in the essential nutrient choline can develop organ dysfunction. We hypothesized that common single nucleotide polymorphisms (SNPs) in genes involved in choline metabolism influence the dietary requirement of this nutrient. Fifty-seven humans were fed a low choline diet until they developed organ dysfunction or for up to 42 days. We tested DNA SNPs for allelic association with susceptibility to developing organ dysfunction associated with choline deficiency. We identified an SNP in the promoter region of the phosphatidylethanolamine N-methyltransferase gene (PEMT; -744 G-->C; rs12325817) for which 18 of 23 carriers of the C allele (78%) developed organ dysfunction when fed a low choline diet (odds ratio 25, P=0.002). The first of two SNPs in the coding region of the choline dehydrogenase gene (CHDH; +318 A-->C; rs9001) had a protective effect on susceptibility to choline deficiency, while a second CHDH variant (+432 G-->T; rs12676) was associated with increased susceptibility to choline deficiency. A SNP in the PEMT coding region (+5465 G-->A; rs7946) and a betaine:homocysteine methyltransferase (BHMT) SNP (+742 G-->A; rs3733890) were not associated with susceptibility to choline deficiency. Identification of common polymorphisms that affect dietary requirements for choline could enable us to identify individuals for whom we need to assure adequate dietary choline intake.
Figures
Figure 1
Three important genes in choline metabolism for which we identified single nucleotide polymorphisms. PEMT = phosphatidylethanolamine N-methyltransferase, which catalyzes the reaction to make phosphatidylcholine (PtdCho) from phosphatidylethanolamine (PtdEtn) using S-adenosylmethionine (SAM) to donate methyl groups; CHDH = choline dehydrogenase, which along with betaine aldehyde dehydrogenase irreversibly oxidizes choline (Cho) to form betaine (Bet); BHMT = betaine:homocysteine methyltransferase, which donates its methyl group to homocysteine (Hcy) to form methionine (Met); PCho = phosphocholine.
Figure 2
Study design. Healthy men and women were fed a baseline diet containing the choline Adequate Intake concentration for 10 days. They were then switched to a low choline diet (<50 mg choline) until they developed signs of organ dysfunction associated with choline deficiency or for up to 42 days. Subjects who developed signs of organ dysfunction were repleted with graded amounts of choline at 10 day intervals until their symptoms disappeared; those without signs of organ dysfunction were fed the 100% choline diet for at least 3 days before being discharged from the study. Some subjects were given a folic acid supplement (400 μg per day) during the depletion and repletion phases, but this did not affect their susceptibility to choline deficiency (from da Costa et al., Am J. Clinc. Nutr., in press).
References
- Zeisel SH, Blusztajn JK. Choline and human nutrition. Ann Rev Nutr. 1994;14:269–296. - PubMed
- Zeisel SH, daCosta KA, Franklin PD, Alexander EA, Lamont JT, Sheard NF, Beiser A. Choline, an essential nutrient for humans. FASEB J. 1991;5:2093–2098. - PubMed
- da Costa KA, Badea M, Fischer LM, Zeisel SH. Elevated serum creatine phosphokinase in choline-deficient humans: mechanistic studies in C2C12 mouse myo-blasts. Am J Clin Nutr. 2004;80:163–170. - PubMed
- Buchman A, Dubin M, Moukarzel A, Jenden D, Roch M, Rice K, Gornbein J, Ament M. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology. 1995;22:1399–1403. - PubMed
- Yao ZM, Vance DE. Head group specificity in the requirement of phosphatidylcholine biosynthesis for very low density lipoprotein secretion from cultured hepatocytes. J Biol Chem. 1989;264:11373–11380. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 ES010126/ES/NIEHS NIH HHS/United States
- M01 RR000046/RR/NCRR NIH HHS/United States
- AG09525/AG/NIA NIH HHS/United States
- DK55865/DK/NIDDK NIH HHS/United States
- R01 DK055865/DK/NIDDK NIH HHS/United States
- ES10126/ES/NIEHS NIH HHS/United States
- R21 ES012997/ES/NIEHS NIH HHS/United States
- DK56350/DK/NIDDK NIH HHS/United States
- ES012997/ES/NIEHS NIH HHS/United States
- P30 DK056350/DK/NIDDK NIH HHS/United States
- P01 AG009525/AG/NIA NIH HHS/United States
- RR00046/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous